Clinical trial
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases
NCT04693377 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases
- Lead sponsor
- M.D. Anderson Cancer Center
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- March 16, 2021
- Completion date
- April 1, 2027
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
castration-resistant prostate carcinoma, metastatic colorectal carcinoma, metastatic malignant neoplasm in the bone, metastatic malignant solid neoplasm, metastatic melanoma, metastatic prostate carcinoma, metastatic renal cell carcinoma, metastatic sarcoma, metastatic thyroid gland carcinoma, metastatic urothelial carcinoma, stage iv colorectal cancer ajcc v8, stage iv prostate cancer ajcc v8, stage iv renal cell cancer ajcc v8, stage iva colorectal cancer ajcc v8, stage iva prostate cancer ajcc v8, stage ivb colorectal cancer ajcc v8, stage ivb prostate cancer ajcc v8, stage ivc colorectal cancer ajcc v8